glp-1 self pay The conversation is moving from injections… to pills. Meet orforglipron, an oral GLP-1 being studied for weight and diabetes. Stop guessing. Start feeling better. Call us to discuss what weight loss The GLP-1 Savings Effect

Per, Niccol, Starbuck's CEO: "The afternoon is a multibillion-dollar opportunity

Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.

#AutoimmuneHealth #GLP1Agonist #InflammationRelief #MetabolicHealth #ChronicIllness

As the use of GLP-1 receptor agonists continues to expand for the treatment of type 2 diabetes and obesity, questions have emerged about their potential gastrointestinal side effectsparticularly gastroesophageal reflux disease (GERD)

Inflammatory bowel diseases (IBD), including Crohns disease (CD) and ulcerative colitis (UC), are chronic, relapsing, intestinal inflammatory disorders with complex and yet unrevealed pathogenesis in which genetic, immunological, and environmental factors play a role